27 Jan 2020 --- Following a string of recent takeovers, Nestlé has entered into an asset purchase agreement with Allergan to acquire the gastrointestinal medications Zenpep and Viokace. Nestlé says the move will expand the company’s medical nutrition business and complement its portfolio of therapeutic products. The deal is expected to be finalized with the merger of biopharmaceutical companies AbbVie and Allergan, which will also see AstraZeneca recover the global rights for brazikumab, a monoclonal antibody. Financial details of the deal have not been disclosed.
